Skip to main content

Table 3 The effects of CR risk levels on multiple metabolic pathways

From: Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

Metabolic pathway

Enriched phenotype

Study (PMID)

Function in cancer

Glycolysis

High CR risk

32631382

Glycolysis is closely associated with proliferation, immune evasion, invasion, metastasis, angiogenesis, and drug resistance in cancers

Nucleotide Metabolism

High CR risk

34138729

Nucleotide metabolism is necessary for tumor proliferation and mediates oncogenic mutations, such as P53 mutation

Cholesterol Biosynthesis

NS

34117857

Cholesterol is an essential component of cell membranes. Aberrant cholesterol metabolism enhances malignant behaviors of tumor cells

FA metabolism

NS

23791484

Tumor proliferation requires FAs for synthesis of membranes and signaling molecules

Glutamate and Glutamine Metabolism

NS

23999442

Glutamine participates in energy formation, redox homeostasis, macromolecular synthesis, and signaling in cancer cells

  1. CR cuproptosis-related, FA fatty acid, NS not statistical